Belite Bio cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 18 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2020 | Dec2021 | Jun2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||
| Net Income | -5.75M | -9.67M | -2.39M | -12.65M | -6.89M | -68.12 | -10.94M | -6.99M | -7.87M | -9.49M | -8.68M | 62.19M | -14.28M | -16.32M | -21.69M | 129.90M | -26.94M | -28.41M |
| Share-based Compensation | 3.40M | 1.98M | 3.58M | 4.20M | 4.21M | 11.71M | ||||||||||||
| Gains from Sales and Divestitures | -0.01M | |||||||||||||||||
| Cash from Operations | -4.44M | -7.47M | -11.46M | -4.60M | -10.38M | |||||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||
| Amortizatization of Intangibles | 0.07M | 0.07M | ||||||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.04M | 0.04M | ||||||||||||||||
| Change in Working Capital | ||||||||||||||||||
| Change in Account Payables | -0.04M | -0.01M | -0.00M | |||||||||||||||
| Change in Accured Expenses | -0.25M | 2.91M | 1.84M | |||||||||||||||
| Other Working Capital Changes | -0.04M | -0.64M | -0.08M | -0.07M | ||||||||||||||
| Investing Activities | ||||||||||||||||||
| Capital Expenditures | -0.02M | -0.07M | -0.39M | |||||||||||||||
| Change in Intangibles | -0.01M | |||||||||||||||||
| Change in Acquisitions & Divestments | 36.94M | 52.73M | ||||||||||||||||
| Cash from Investing Activities | -0.02M | -0.06M | -0.39M | -26.01M | -303.73M | |||||||||||||
| Financing Activities | ||||||||||||||||||
| Other financing activities | 0.00M | 28.75M | 102.64M | |||||||||||||||
| Change in Capital Stock | ||||||||||||||||||
| Net Shares Issued and Repurchased | 2.81M | 0.75M | 1.70M | 1.01M | 1.27M | 1.15M | ||||||||||||
| Net Equity Issued and Repurchased | 23.00M | 18.25M | 49.35M | |||||||||||||||
| Misc. | ||||||||||||||||||
| Cash from Financing Activities | -0.58M | 39.77M | 510.12M | |||||||||||||||
| Exchange Rate Effect | -0.16M | -0.37M | -0.28M | -0.10M | ||||||||||||||
| Change in Cash | -8.27M | 8.88M | 195.90M | |||||||||||||||
| Free Cash Flow | -4.42M | -7.40M | -11.06M | -4.60M | -10.38M | |||||||||||||
| Net Cash Flow | -4.46M | -8.11M | -11.85M | 9.16M | 196.00M |